Quoin Pharma approves 1-for-35 reverse ADS split effective April 9 to meet Nasdaq bid price rule

Quoin Pharmaceuticals, Ltd.

ADS ratio changes from 1 ADS = 1 ordinary share to 1 ADS = 35 ordinary shares, effective April 9, 2025.
Reverse split aims to increase ADS price to comply with Nasdaq's $1.00 minimum bid price requirement.
Ordinary shares unaffected; new CUSIP for ADS will be 74907L409; ticker QNRX unchanged.
Holders of DRS and DTC ADSs need no action; certificated holders must surrender every 35 old ADSs for 1 new ADS.
Company cautions that it cannot guarantee the ratio change will achieve or maintain Nasdaq compliance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.